Friday, March 18, 2022 7:14:55 AM
Why has Activ-3b NIH/NIAID trial taken ~1 year to get ~400 patients & ~18 months to get 644 patients?
+ While BP trials fill 1,000 patient trials in less than 1 month.
Can NIH/NIAID help accelerate awareness and enrollments? If not, why not?
+ Why hasn't NIH/NIAID done more to support this trial?
Are severely ill Covid patients a focus for NIH/NIAID? If not, why not?
~ posted by Equalizer, Y@h00 RLFTF finance conversations
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM